Ceftriaxone and Breathing difficulty - a phase IV clinical study of FDA data

Summary:

Breathing difficulty is found among people who take Ceftriaxone, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Ceftriaxone and have Breathing difficulty. It is created by eHealthMe based on reports of 33,453 people who have side effects when taking Ceftriaxone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 20, 2023

33,453 people reported to have side effects when taking Ceftriaxone.
Among them, 1,294 people (3.87%) have Breathing difficulty.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 33,567 Ceftriaxone users for its effectiveness, alternative drugs and more.

What is Breathing difficulty?

Breathing difficulty is found to be associated with 5,029 drugs and 5,923 conditions by eHealthMe.

Number of Ceftriaxone and Breathing difficulty reports submitted per year:

Could Ceftriaxone cause Breathing difficulty?

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and have Breathing difficulty?

Check whether Breathing difficulty is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .

Related studies

How severe was Breathing difficulty and when was it recovered:

Breathing difficulty in Ceftriaxone

Expand to all the drugs that have ingredients of ceftriaxone sodium:

Breathing difficulty and drugs with ingredients of ceftriaxone sodium (1,939 reports)

Alternative drugs to, pros and cons of Ceftriaxone:

Ceftriaxone (33,567 reports)

Common Ceftriaxone side effects:

Fever: 2,393 reports
Drug ineffective: 1,874 reports
Pneumonia: 1,715 reports
Rashes (redness): 1,662 reports
Breathing difficulty: 1,364 reports
Thrombocytopenia (decrease of platelets in blood): 1,275 reports
Diarrhea: 1,256 reports
Hypotension (abnormally low blood pressure): 1,244 reports

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Breathing difficulty treatments and more:

Breathing difficulty (579,779 reports)

COVID vaccines that are related to Breathing difficulty:

Common drugs associated with Breathing difficulty:

All the drugs that are associated with Breathing difficulty:

Breathing difficulty (5,029 drugs)

Common conditions associated with Breathing difficulty:

Asthma: 40,041 reports
Primary pulmonary hypertension: 34,524 reports
High blood pressure: 26,686 reports
Rheumatoid arthritis: 25,046 reports
Chronic obstructive pulmonary disease: 24,688 reports
Pain: 15,402 reports

All the conditions that are associated with Breathing difficulty:

Breathing difficulty (5,923 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone) and Ceftriaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.